PureTech News and Activities

PureTech is one of the...

• FTSE SmallCaps.

PureTech is a company listed under the stock ticker PRTC (US).

View the org chart displaying its 49 main executives

Most searched biographies at PureTech

• Robert Lyne, Chief Executive Officer
• Sharon Barber-Lui, Interim Chairman of the Board
• Kiran Mazumdar-Shaw, Director

Popular executive movements at PureTech

• Robert Lyne, who was Interim Chief Executive Officer, is promoted to Chief Executive Officer  (posted on December 18 2025).

Create your alert
to follow the executive moves at PureTech.

PureTech has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by PureTech

• Notice of Half-Yearly Results | PureTech Health
• PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan | PureTech Health
• PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate | PureTech Health
• PureTech Founded Entity Akili Announces Public Company Board of Director Nominees | PureTech Health
• PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb) | PureTech Health
• PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia | PureTech Health
• PureTech News | PureTech Health
• PureTech Founded Entity Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million | PureTech Health
• Results of Annual General Meeting | PureTech Health
• PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute "Long" COVID with Respiratory Complications | PureTech Health
• View more press releases Close

Social media about PureTech

• PureTech on Wikipedia, Google News & Yahoo Finance
• PureTech on LinkedIn, X (Twitter) & YouTube